Proteomics identifies a type I IFN, prothrombotic hyperinflammatory circulating COVID-19 neutrophil signature distinct from non-COVID-19 ARDS
Authors:
- Leila ReyesLRLeila Reyes
- Manuel Alejandro Sanchez-GarciaMSManuel Alejandro Sanchez-Garcia
- Tyler MorrisonTMTyler Morrison
- Andrew J.M. HowdenAHAndrew J.M. Howden
- Emily R. WattsEWEmily R. Watts
- Simone ArientiSASimone Arienti
- Pranvera SadikuPSPranvera Sadiku
- Patricia CoelhoPCPatricia Coelho
- Ananda S MirchandaniAMAnanda S Mirchandani
- David HopeDHDavid Hope
- Jo SingletonJSJo Singleton
Preprint
Abstract
Summary: Understanding the mechanisms by which infection with SARS-CoV-2 leads to acute respiratory distress syndrome (ARDS) is of significant clinical interest given the mortality associated with severe and critical coronavirus induced disease 2019 (COVID-19). Neutrophils play a key role in the lung injury characteristic of non-COVID-19 ARDS, but a relative paucity of these cells is observed at post-mortem in lung tissue of patients who succumb to infection with SARS-CoV-2. With emerging evidence of a dysregulated innate immune response in COVID-19, we undertook a functional proteomic survey of circulating neutrophil populations, comparing patients with COVID-19 ARDS, non-COVID-19 ARDS, moderate COVID-19, and healthy controls. We observe that expansion of the circulating neutrophil compartment and the presence of activated low and normal density mature and immature neutrophil populations occurs in both COVID-19 and non-COVID-19 ARDS. In contrast, release of neutrophil granule proteins, neutrophil activation of the clotting cascade and formation of neutrophil platelet aggregates is significantly increased in COVID-19 ARDS. Importantly, activation of components of the neutrophil type I IFN responses is specific to infection with SARS-CoV-2 and linked to metabolic rewiring. Together this work highlights how differential activation of circulating neutrophil populations may contribute to the pathogenesis of ARDS, identifying processes that are specific to COVID-19 ARDS.Keywords
All Related Versions
- Published version: Wellcome Open Research, 6, 38.
This publication has 36 references indexed in Scilit:
- Tissue-specific tolerance in fatal Covid-19medRxiv, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Clinical and immunological features of severe and moderate coronavirus disease 2019Journal of Clinical Investigation, 2020
- Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver MicrotissuesMolecular & Cellular Proteomics, 2015
- Acute Respiratory Distress SyndromeJAMA, 2012
- Hypoxia and InflammationNew England Journal of Medicine, 2011
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Role of Tidal Volume, FRC, and End-inspiratory Volume in the Development of Pulmonary Edema following Mechanical VentilationAmerican Review of Respiratory Disease, 1993
- Leukocytes are required for increased lung microvascular permeability after microembolization in sheep.Circulation Research, 1981
- Alterations of the Gas Exchange Apparatus in Adult Respiratory Insufficiency Associated with SepticemiaAmerican Review of Respiratory Disease, 1977